<DOC>
	<DOCNO>NCT02562859</DOCNO>
	<brief_summary>The purpose study evaluate amount GLPG1837 metabolite present blood ( relative bioavailability ) single oral administration 500 mg GLPG1837 give oral suspension fast condition well tablet formulation fast fed condition , male healthy subject . Also , safety tolerability single oral dose 500 mg GLPG1837 give oral suspension fast condition well tablet formulation fast fed condition , assess . Twelve subject receive GLPG1837 3 occasion single dose administration : oral suspension fast , oral tablet , fed fast . Treatment administration separate wash-out period least 6 day .</brief_summary>
	<brief_title>Oral Bioavailability Solid Formulation GLPG1837 With Without Food</brief_title>
	<detailed_description />
	<criteria>Healthy male , age 1850 year BMI 1830 kg/m2 Any condition might interfere procedure test study Drug alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>